Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP974407.RAWyw4Wri5F5IbOxUKmbfZ_XFtvZ8L9SJY2QS9ptyJFaI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP974407.RAWyw4Wri5F5IbOxUKmbfZ_XFtvZ8L9SJY2QS9ptyJFaI130_assertion type Assertion NP974407.RAWyw4Wri5F5IbOxUKmbfZ_XFtvZ8L9SJY2QS9ptyJFaI130_head.
- NP974407.RAWyw4Wri5F5IbOxUKmbfZ_XFtvZ8L9SJY2QS9ptyJFaI130_assertion wasGeneratedBy ECO_0000203 NP974407.RAWyw4Wri5F5IbOxUKmbfZ_XFtvZ8L9SJY2QS9ptyJFaI130_provenance.
- NP974407.RAWyw4Wri5F5IbOxUKmbfZ_XFtvZ8L9SJY2QS9ptyJFaI130_assertion wasDerivedFrom befree-20150227 NP974407.RAWyw4Wri5F5IbOxUKmbfZ_XFtvZ8L9SJY2QS9ptyJFaI130_provenance.
- NP974407.RAWyw4Wri5F5IbOxUKmbfZ_XFtvZ8L9SJY2QS9ptyJFaI130_assertion SIO_000772 11927838 NP974407.RAWyw4Wri5F5IbOxUKmbfZ_XFtvZ8L9SJY2QS9ptyJFaI130_provenance.
- NP974407.RAWyw4Wri5F5IbOxUKmbfZ_XFtvZ8L9SJY2QS9ptyJFaI130_assertion evidence source_evidence_literature NP974407.RAWyw4Wri5F5IbOxUKmbfZ_XFtvZ8L9SJY2QS9ptyJFaI130_provenance.
- NP974407.RAWyw4Wri5F5IbOxUKmbfZ_XFtvZ8L9SJY2QS9ptyJFaI130_assertion description "[Statistically significant increases in asthma risk were also observed among the whole study population for the concurrent presence of the GSTM1 null genotype and either NAT1 (odds ratio [OR] 4.53, 95% CI 1.76 to 11.6) or NAT2 (OR 3.12, 95% CI 1.11 to 8.78) slow acetylator genotypes, and of NAT1 and NAT2 slow acetylator genotypes (OR 4.20, 95% CI 1.51 to 11.6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974407.RAWyw4Wri5F5IbOxUKmbfZ_XFtvZ8L9SJY2QS9ptyJFaI130_provenance.